https://www.healthcentral.com/article/marijuana-and-chronic-pain-qa-with-dr-david-barton
Marijuana and Chronic Pain: Q&A with Dr. David Barton
Celeste Cooper, RN / @FibroCFSWarrior, Health Professional

marijuana         Credit:  Thinkstock

Dr. David J. Barton (AKA Dr. B), a conservative physician by personality and training, says it required an evolutionary process to arrive at his present clinical outlook on medical marijuana.

What is your medical background?**

Dr. B**: I was a double-boarded general surgery trained plastic surgeon until I became disabled and retrained in Pain Medicine at the University of Utah. I hold memberships in the American Academy of Pain Medicine, the International Cannabinoid Research Society and the Hawaii Medical Society.

How did your opinion on cannabis medicine evolve?**

Dr. B**: I was hindered from a career in surgery, causing a neck and arm condition that lead to chronic pain. That led me to where I am today. Much of my philosophy is guided by my personal experiences with severe pain and the failed treatments.

I became frustrated by poor treatment outcomes. For many pain conditions, traditional medicine included aggressive treatments and dangerous levels of medicines. Having no personal experience with marijuana use, I learned by listening to patients who found significant relief using cannabis. With further study, I realized the truth about cannabis and its potential to relieve suffering in a safe and effective manner.

What is cannabis medicine?**

Dr. B**: For the Pain Doc, cannabis medicine represents a naturopathic, legitimate alternative for treating chronic neuropathic pain and muscular conditions using a variety of cannabis based medicines.

The U.S. National Institutes of Health/National Cancer Institute states the known benefits include:

Antiemetic effects (effective against vomiting and nausea)
Appetite stimulation
Pain relief
Improved sleep
Symptom management
Direct antitumor effect
End of life care
Cannabis medicine focuses on treating a variety of medical conditions.

Are there risks?**

Dr. B**: There are risks to any treatment. Seldom headlined are the consequences of undertreated or untreated pain. According to the American Osteopathic Association, chronic pain “affects more Americans than cancer, diabetes, and heart disease combined.”

Patients and physicians should discuss potential negative effects. About 90 percent of my patients use very small amounts of cannabis, and learn quickly how to avoid problems. And like with any medication, I screen for the small minority of those who may be prone to misuse and addiction.

When an individual’s health problems are addressed by a qualified healthcare provider, risks, significantly less than traditional medications, are minimized.

Many say THC and CBD** transform pain signals between peripheral nerves, the spinal cord and brain. Do you agree?**

Dr. B**: Yes. At the 2013 American Academy of Pain Medicine meeting, Dr. Michael Moskowitz said, “preclinical studies, surveys, case studies and randomized double-blind placebo-controlled trials with cannabis have all shown its effectiveness in chronic pain conditions … Cannabis works to settle down the processing of wind-up (centralization) and is the only drug known to do so. It reduces inflammatory pain in the peripheral nerves, and has a unique mechanism for pain reduction unlike any other medicine.”

The complex interaction between innate opioid and cannabinoid systems is not well understood. But with effort and opportunity, we can unravel the mysteries of cannabis science.

How does MMJ stack up against other painkillers?**

Dr. B**: Studies show MMJ can be as effective as opioids. Many people are able to eliminate or significantly reduce their use of opioid pain pills. Cannabis also treats other problems associated with chronic pain, such as sleep, mood disorders, and myofascial spasms and pain, thereby reducing the need for additional medications that have potential side effects or drug interactions.

Is there a cultural transformation regarding MMJ?**

Dr. B**: Yes. This was most evident at a recent NIH symposium (Marijuana and Cannabinoids: A Neuroscience Research Summit) that took place in Bethesda this past spring, wherein, the medical use of cannabis was clearly discussed.

Over the past few years, we have all seen the direct medicinal effects of cannabis in the media by high profile people and entities. The most dramatic have been children with intractable seizures whose parents are directly challenging hostile politicians. The second group is our veterans with service-related conditions who find relief with medical cannabis use.

Patients, their love ones, and organizations have teamed up with activist physicians and political allies to challenge the status quo of government. The tsunami of change in every state has been accelerated by opioid related deaths.

How do you counsel patients?**

Dr. B**: The patient must have a qualifying condition according to the laws of Hawaii, where I practice. I expect patients to act responsibly and follow the laws that govern MMJ access and use. I discuss various delivery systems with my patients. The majority use inhalation delivery. Oils, edibles, and topical ointments are in strong demand. I have seen great results for autoimmune conditions using high CBD low THC cannabis based juice, which provides pain relieving, strong anti-inflammatory effects without psychogenic effects.

Our goal is to combine traditional multi-disciplinary therapies with our patient’s right to use medicinal cannabis to improve their outcome. (See An Elephant Called Pain.)

David J. Barton, MD is a clinician in Pain Medicine and a Medical Political Activist with more than 31 years of experience as a physician. He is fellowship trained in Pain Medicine, and became board certified in Pain Medicine by the American Board of Pain Medicine in 2005. Past board certifications include General Surgery (1992) and Plastic Surgery (1995). He is owner and founder of Hawaiian-Pacific Pain and Palliative Care and focuses his practice on chronic pain and end of life care. Dr. Barton has personally lived in the “Pain World” for nearly 20 years.

Celeste Cooper, RN, is a chronic pain patient, freelance writer, and contributor to the Health Central Community. She is also lead author of five published self-help books and enjoys writing and advocating for people living with chronic pain as a participant in a local patient leadership group and the PAINS Project. She is lead author of Integrative therapies for Fibromyalgia, Chronic Fatigue Syndrome, and Myofascial Pain and the Broken Body, Wounded Spirit: Balancing the See-Saw of Chronic Pain book series.  Connect with Celeste through her website CelesteCooper.com, Twitter @FibroCFSWarrior, or follow her FB page:
https://www.facebook.com/Chronic.pain.therapies.advocacy/
Published On: Aug 1st 2016

 

For more on medical cannabis:

https://madisonarealymesupportgroup.com/2017/01/23/nasem-report-on-cannabis/

https://madisonarealymesupportgroup.com/2017/09/28/cbd-for-pain/

https://madisonarealymesupportgroup.com/2015/05/19/marijuana-the-miracle-herb/

http://outbreaknewstoday.com/new-hampshire-reports-2nd-jamestown-canyon-virus-case-27643/  Sept. 2017

New Hampshire health officials have recorded the second human Jamestown Canyon virus (JCV) case of the year in an adult from Goffstown. This follows a case confirmed in mid-August in Hanover.

Image/Elionas
Image/Elionas

It is likely that this case was acquired in New Hampshire, but due to recent travel, location of exposure is not certain.

“As we head into the fall, it’s important for people to remember that mosquito-borne diseases like Jamestown Canyon Virus are still a risk in New Hampshire,” said State Epidemiologist Dr. Benjamin Chan. “We want residents and visitors to continue to enjoy the outdoors, but they should take steps to protect themselves from mosquito bites as long as mosquitoes are still around.”

LISTEN: Powassan virus: The spread is inevitable

Until the second hard frost of the season, residents and visitors to New Hampshire should continue to protect themselves and their family members from mosquito-borne diseases by using an effective mosquito repellant that contains 30% DEET, wearing long sleeves and pants at dawn and dusk when mosquitoes are most active, and removing standing water from around your home so mosquitoes do not have a place to breed. Repellents with picaridin, IR3535 and some oil of lemon eucalyptus and para-menthane-diol products also provide protection against mosquito bites. A hard frost is defined as two consecutive hours of temperatures below 28 degrees Fahrenheit.

Related: Iowa reports 1st West Nile virus death of 2017

Initially described in the early 1970s, JCV is a mosquito-borne pathogen that circulates widely in North America primarily between deer and a variety of mosquito species, but it can also infect humans. Reports of JCV in humans are rare (Since 2000, more than 50 cases of JCV have been identified nationally. The cases have primarily been in the Midwest and Northeast) and most reported illnesses caused by Jamestown Canyon virus have been mild, but moderate-to-severe central nervous system involvement has been reported.

 

https://www.cambridge.org/core/journals/parasitology/article/validation-of-droplet-digital-pcr-for-the-detection-and-absolute-quantification-of-borrelia-dna-in-ixodes-scapularis-ticks/A47CEB12C767C573BEB7AD8BD8E3A252

Validation of droplet digital PCR for the detection and absolute quantification of Borrelia DNA in Ixodes scapularis ticks

Summary

We evaluated the QX200 Droplet Digital PCR (ddPCR™, Bio-Rad) system and protocols for the detection of the tick-borne pathogens Borrelia burgdorferi and Borrelia miyamotoi in Ixodes scapularis nymphs and adults collected from North Truro, Massachusetts. Preliminary screening by nested PCR determined positive infection levels of 60% for B. burgdorferi in these ticks. To investigate the utility of ddPCR as a screening tool and to calculate the absolute number of bacterial genome copies in an infected tick, we adapted previously reported TaqMan®-based qPCR assays for ddPCR. ddPCR proved to be a reliable means for detection and absolute quantification of control bacterial DNA with precision as low as ten spirochetes in an individual sample. Application of this method revealed the average carriage level of B. burgdorferi in infected I. scapularis nymphs to be 2291 spirochetes per nymph (range: 230–5268 spirochetes) and 51,179 spirochetes on average in infected adults (range: 5647–115,797). No ticks naturally infected with B. miyamotoi were detected. The ddPCR protocols were at least as sensitive to conventional qPCR assays but required fewer overall reactions and are potentially less subject to inhibition. Moreover, the approach can provide insight on carriage levels of parasites within vectors.

 

**Comment**

While this is a great start, there are many other pathogens to be concerned with besides Borrelia burgdorferi (Bb), the agent of Lyme Disease:  https://madisonarealymesupportgroup.com/2017/07/01/one-tick-bite-could-put-you-at-risk-for-at-least-6-different-diseases/, and there are many more besides the six mentioned in this article.  Bartonella has not been proven conclusively to be transmitted by ticks, but it is highly likely.  It is also a frequent coinfection and can be spread by:

Arthropod vectors including fleas and flea feces, biting flies such as sand flies and horn flies, the human body louse, mosquitoes, and ticks; through bites and scratches of reservoir hosts; and potentially from needles and syringes in the drug addicted. Needle stick transmission to veterinarians has been reported. There is documentation that cats have received it through blood transfusion. 3.2% of blood donors in Brazil were found to carry Bartonella in their blood. Bartonella DNA has been found in dust mites. Those with arthropod exposure have an increased risk, as well as those working and living with pets that have arthropod exposure. 28% of veterinarians tested positively for Bartonella compared with 0% of controls. About half of all cats may be infected with Bartonella – as high as 80% in feral cats and near 40% of domestic cats. In various studies dogs have close to a 50% rate as well. Evidence now suggests it may be transmitted congenitally from mother to child – potentially leading to birth defects.  https://madisonarealymesupportgroup.com/2016/01/03/bartonella-treatment/

There is much work yet to be done.

 

 

 

 

 

https://jameslyonsweiler.com/2017/09/27/desperation-over-pertussis-vaccine-failure-is-driving-pharma-to-use-scary-propaganda/  James Lyons-Weiler, PhD, Sept 26, 2017

Desperation Over Pertussis Vaccine Failure is Driving Pharma to Use Scary Propaganda

IF YOU HAVEN’T SEEN the commercial in which GlaxoSmithKline has ripped a page out of 1930’s Nazi Germany, you won’t believe your eyes.  In this commercial, and in associated propaganda posters, grandparents are demonized and turned into wolves – leering at their own grandchildren.

pharmanazipropaganda1

Here, non-vaccinated grandparents are depicted as animals, less than human, and as a dire threat to a helpless infant. With the insinuation that grandparents could be responsible for any case of infantile pertussis infection, the message pitches family member against family member. Joseph Goebbels (Nazi propaganda Reich Minister of Propaganda of Nazi Germany from 1933 to 1945) would be proud that their tactic of de-humanizing part of the population is alive and well in 2017.

How accurate is the message is that grandparents can spread whooping cough (pertussis) to their new infant?

Yes, pertussis infection is contagious. What GSK has left out, however, is the fact that individuals who vaccinated can be turned into silent carriers, based on two reasons.

(1)   The vaccine itself, not low vaccination rates, can lead to persistent asymptomatic pertussis infection.
(2) As a result of (1), the TDaP/DTaP vaccination program has failed. 

That’s not my opinion.  That is scientific consensus:  http://pediatrics.aappublications.org/content/pediatrics/135/6/1130.full.pdf

In the commercial, we see that the grandmother has symptoms (a slight cough or sniffle).  This is meant to imply that an infection is the threat.  In reality, asymptomatic wild-type pertussis carriers are the threat, and they are created by exposure of the immune system to the failed vaccine.

The realization that TDaP/DTaP has failed has led to experimental use of TDaP (with no safety or efficacy data: Source: CDC) during pregnancy.  It is “hoped” that it will prove effective and safe.  Studies after the introduction of TDaP during pregnancy are biased: they removed (excluded) women who were at risk of complications.  These women are not screened out of the clinical vaccination program, however, and this represents a consistent failure of translational research on vaccines.  The FDA stands by while vaccines never tested on a given population are applied, and they are thereby complicit and responsible for the fetal deaths and other serious adverse events, such as autism, that can result from maternal immune activation during pregnancy.

New York Times Calls for Citizens to Break Federal Law

Today, The NYT ran a piece asking the question “Can I Spread the Word About an Unvaccinated Child?” and the author counsels the public to go ahead, spread the word about unvaccinated children.  Each person, and their children, are entitled to medical privacy under the The HIPAA Privacy Rule, which establishes national standards to protect individuals’ medical information.

Meanwhile, in 2017 Germany, Kindergartens must report their parents to the State if they have opted out of vaccination (Source: Reuters):

german prop

The Nazi propaganda protocols are well in place.  Turn your enemy (the informed, non-vaccinating public) into animals, and then turn people against each other. The next step is the argue that those who do not vaccinate do not have the same rights as those who do vaccinate.  Luckily, 48/50 states in the US allow non-medical exemptions for children whose parents are informed of the actual risks associated with vaccines.

Here are some additional reminders of disgusting Nazi propaganda posters depicting members of the Jewish faith into sub-humans.

1The caricatures from Musée des Horreurs include heads or faces of prominent Jews, Dreyfus supporters, and Republican statesman placed on grotesque animal bodies.  http://library.duke.edu/digitalcollections/museedeshorreurs/about/

Remember, the TdaP/DTaP not only fails to protect individuals from infection – it can create silent carriers.  The logical outcome of continued use of TDaP in any population is a pertussis epidemic. Here a a Scientific American story on the problem:  https://www.scientificamerican.com/article/baboon-study-reveals-new-shortcoming-of-pertussis-vaccine/

With symptoms, infected family members could know they should stay away from baby, and they could seek treatment.  Pertussis infection is curable via antibiotics.

With the vaccine, family members could unknowingly spread pertussis to their newborns.

We don’t need propaganda.  We need CDC and ACIP to adult, and pull TdaP/DTaP from the schedule.  Better yet, GSK should pull it themselves.  If CDC/ACIP or GSK won’t, we need the FDA to ban the vaccine, forcing the development of safer, more effective means of controlling pertussis.

In the meantime, babies are at risk of pertussis infection from the vaccinated, silent carriers, and CDC/ACIP, FDA, and GSK – NOT grandparents – are responsible for the associated morbidity and mortality.

____________________________________________________________________________________________

For more on Vaccines:  https://madisonarealymesupportgroup.com/2017/04/06/video-how-vaccines-are-made/

https://madisonarealymesupportgroup.com/2017/09/21/aluminum-flawed-assumptions-fueling-autoimmune-disease-and-lyme/

https://madisonarealymesupportgroup.com/2017/09/19/autism-aluminum-adjuvant-link-corroborated/

https://madisonarealymesupportgroup.com/2017/03/30/ty-bollinger-the-truth-about-vaccines-series/  (I highlight Dr. Gentempo’s 9 part vaccine series which covers nearly every vaccine)

https://madisonarealymesupportgroup.com/2017/07/21/class-and-race-profiling-in-the-vaccine-culture-war/

https://madisonarealymesupportgroup.com/2017/09/07/20268/  New Lyme Vaccine Coming Soon.  Caveat Empter – Buyer Beware!

https://madisonarealymesupportgroup.com/2017/07/08/dark-ages-of-immunization-medicine-are-now/

 

https://www.linkedin.com/pulse/i-came-up-what-think-may-durable-treatment-lyme-were-book-steven/

22141057_678945278977521_5522604736941259639_n

Dr. Phillips has closed his practice to new patients as the waiting list was 1.5 years long.  Wanting to focus on broader issues he hired a nurse practitioner and another doctor.

The important news for patients is he has come upon a treatment he feels is a durable remedy for late stage Lyme and bartonella and is raising money to study it in mice for proof.  After that he plans on writing a book about the process.

Dr. Phillips

He and Dana Parish have started a Q & A video series on Facebook to answer questions about Lyme, bartonella, and other co-infections.

https://www.facebook.com/lymebook/videos/679186688953380/  Video 1

If you haven’t seen Dr. Phillips in action before, you are missing a real treat.  This man I can level the CDC in mere minutes.  https://madisonarealymesupportgroup.com/2016/07/01/unedited-interview-with-dr-phillips-fox-5-ny/

https://madisonarealymesupportgroup.com/2016/04/03/dr-phillips-does-it-again/

https://madisonarealymesupportgroup.com/2016/07/11/dr-phillips-completely-trounces-cdc/